Insmed | INSM

Aktienkurs
126.95
Täglich Wechseln
0.27 0.21%
Monatlich
28.56%
Jährlich
-10.93%
Q3 Prognose
116.00

EPS Referenz Zeit Aktuell Konsens Zuletzt
2026-10-22 FY2026Q3 AM -0.61 -1.75
2026-08-06 FY2026Q2 AM -0.06 -0.75 -1.70
2026-05-07 FY2026Q1 AM -0.76 -0.99 -1.42
2026-02-19 FY2025Q4 AM -1.54 -1.28 -1.32
2025-10-30 FY2025Q3 AM -1.75 -1.34 -1.27



Preis Chg Tag Jahr Datum
BioMarin Pharmaceutical 66.13 -0.30 -0.45% 16.53% 2026-09-04
Cytokinetics 73.27 -0.68 -0.92% 47.28% 2026-09-04
DBV Technologies 13.70 0.09 0.66% 48.59% 2026-09-03
Gilead Sciences 150.64 -0.58 -0.38% 30.93% 2026-09-04
Heron Therapeutics 0.34 0.01 4.24% -73.94% 2026-09-04
Insmed 126.95 0.27 0.21% -10.93% 2026-09-04
Novartis 159.76 -3.22 -1.98% 23.13% 2026-09-04
Ultragenyx Pharmaceutical 14.84 -11.69 -44.06% -52.56% 2026-09-03
Regeneron Pharmaceuticals 831.68 -11.79 -1.40% 45.05% 2026-09-04
Sarepta Therapeutics 22.13 -0.86 -3.74% 19.88% 2026-09-04

Preis Tag Jahr Datum
USND 26475 -108.74 -0.41% 22.00% 2026-09-04
US2000 2972 3.68 0.12% 24.29% 2026-09-04